These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21169188)

  • 1. Low back pain following intravenous administration of amiodarone.
    Tsikrikas S; Charalampous C; Letsas KP; Efremidis M; Sideris A
    Hellenic J Cardiol; 2010; 51(6):544-5. PubMed ID: 21169188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute low back pain during intravenous administration of amiodarone: a report of two cases.
    Korantzopoulos P; Pappa E; Karanikis P; Kountouris E; Dimitroula V; Siogas K
    Int J Cardiol; 2005 Feb; 98(2):355-7. PubMed ID: 15686794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute disabling low-back pain during intravenous administration of amiodarone: could intravenous to oral switch therapy be a safe strategy?
    Manzano-Fernández S; Sánchez M; Moreno-Flores V; García-Alberola A
    Cardiology; 2010; 117(4):275-7. PubMed ID: 21273769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute severe back pain radiating to the whole body during intravenous administration of amiodarone.
    Yan Y; Shen H
    Int J Clin Pharmacol Ther; 2015 Jul; 53(7):561-2. PubMed ID: 25907175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute epigastric and low back pain during amiodarone infusion; is it the drug or the vehicle to blame?
    Petrou E; Iakovou I; Boutsikou M; Girasis C; Mavrogeni S; Pavlides G
    Heart Lung; 2014; 43(1):60-1. PubMed ID: 24239300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low back pain induced by i.v. amiodarone.
    Adams ML; Kujawski SZ; Bollinger J; Prom R
    Am J Health Syst Pharm; 2014 May; 71(10):782-4. PubMed ID: 24780481
    [No Abstract]   [Full Text] [Related]  

  • 7. Anaphylaxis to intravenous amiodarone.
    Fransi S; Briedis J
    Anaesth Intensive Care; 2004 Aug; 32(4):578-9. PubMed ID: 15675221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early-onset acute toxic hepatitis induced by intravenous amiodarone administration].
    González Galilea A; García Sánchez MV; la Mata García M; Miño Fugarolas G
    Gastroenterol Hepatol; 2002; 25(6):392-4. PubMed ID: 12069701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute hepatitis caused by intravenous amiodarone].
    Paniagua Clusells J; Arcusa Gavalda R; Goma Masip F; Pons Masanes S; Soler Masana JM
    Rev Esp Cardiol; 1996 May; 49(5):384-5. PubMed ID: 8744394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute liver injury after intravenous amiodarone: a case report.
    Verhovez A; Elia F; Riva A; Ferrari G; Aprà F
    Am J Emerg Med; 2011 Sep; 29(7):843.e5-6. PubMed ID: 20870371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of oral amiodarone as a chronic treatment in a patient with prior fulminant hepatitis due to intravenous amiodarone].
    López-Gómez D; Nicolás J; Frigola JM; Manito N; Esplugas E
    Rev Esp Cardiol; 1999 Mar; 52(3):201-3. PubMed ID: 10193175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse effects of amiodarone.
    Jafari-Fesharaki M; Scheinman MM
    Pacing Clin Electrophysiol; 1998 Jan; 21(1 Pt 1):108-20. PubMed ID: 9474655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal acute liver failure after intravenous amiodarone administration.
    Li JG; Yang TC; Yu DM; Ren TH
    J Formos Med Assoc; 2015 Mar; 114(3):294-6. PubMed ID: 23953514
    [No Abstract]   [Full Text] [Related]  

  • 14. Amiodarone-induced thrombosis: a case series and brief review of the literature.
    Iqbal FM; Chawla B; Koneru J; Bikkina M
    Am J Ther; 2012 Sep; 19(5):389-91. PubMed ID: 21150769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute hepatotoxicity from intravenous amiodarone in a patient on hemodialysis].
    Bucco S; Arazzi M; Giunta F; Grabocka X; Longo MO; Silvestri S; Spetrino N; Tondo M; Vigilante G; Bonomini M
    G Ital Nefrol; 2016; 33(1):. PubMed ID: 26913742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of a hypotensive effect with rapid administration of a new aqueous formulation of intravenous amiodarone.
    Somberg JC; Timar S; Bailin SJ; Lakatos F; Haffajee CI; Tarjan J; Paladino WP; Sarosi I; Kerin NZ; Borbola J; Bridges DE; Molnar J;
    Am J Cardiol; 2004 Mar; 93(5):576-81. PubMed ID: 14996582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylaxis during intravenous administration of amiodarone.
    Okuyan H; Altin C; Arihan O
    Ann Card Anaesth; 2013; 16(3):229-30. PubMed ID: 23816686
    [No Abstract]   [Full Text] [Related]  

  • 18. [Guidelines for use of amiodarone (Cordarone). A potent anti-arrhythmic agent that may have problematic adverse effects].
    Gjesdal K; Amlie JP; Orning OM
    Tidsskr Nor Laegeforen; 1993 Jun; 113(17):2107-10. PubMed ID: 8337671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Hepatotoxicity of Intravenous Amiodarone: Case Report and Review of the Literature.
    Chen CC; Wu CC
    Am J Ther; 2016; 23(1):e260-3. PubMed ID: 25259952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PM101: a cyclodextrin-based intravenous formulation of amiodarone devoid of adverse hemodynamic effects.
    Cushing DJ; Kowey PR; Cooper WD; Massey BW; Gralinski MR; Lipicky RJ
    Eur J Pharmacol; 2009 Apr; 607(1-3):167-72. PubMed ID: 19232340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.